Rh. Vonderheide et al., The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes, IMMUNITY, 10(6), 1999, pp. 673-679
The discovery of tumor-associated antigens (TAA) in certain human malignanc
ies has prompted renewed efforts to develop antigen-specific immunotherapy
of cancer. However, most TAA described thus far are expressed in one or a f
ew tumor types, and, among patients with these types of tumors, TAA express
ion is not universal. Here, we characterize the telomerase catalytic subuni
t (hTERT) as a widely expressed TAA capable of triggering antitumor cytotox
ic T lymphocyte (CTL) responses. More than 85% of human cancers exhibit str
ong telomerase activity, but normal adult tissues, with few exceptions, do
not. In a human system, CD8(+) CTL specific for an hTERT peptide and restri
cted to MHC HLA-A2 lysed hTERT(+) tumors from multiple histologies. These f
indings identify hTERT as a potentially important and widely applicable tar
get for anticancer immunotherapeutic strategies.